Bladder cancer is a malignant (cancerous) tumor of the lining of the bladder. For most patients, the first symptom is blood in the urine, which may or may not be visible to the naked eye.
Max Kates, M.D., answers questions about bladder cancer, diagnosis and available treatment options.
Adults: 410-955-6100 Pediatrics: 410-955-6108
Following bladder removal surgery, John shares his story about receiving diagnosis and treatment from the multidisciplinary team at Johns Hopkins.
After receiving treatment for non-muscle invasive bladder cancer and discovering that his tumor was not responding, Dr. Warren Brill was referred to Johns Hopkins.
At your consultation, your surgeon will discuss the various bladder cancer treatment options, which will depend on the stage and grade of your tumor, and whether the cancer has invaded the wall of the bladder or spread to other organs.
Some of our experts reflect on the ways the GBCI is building on a foundation of discovery to drive the future of bladder cancer treatment.
Our cancer specialists in radiation oncology, urologic surgery, medical oncology, radiology, pathology and research work together to provide patients with expert care. These leading minds in cancer discuss each patient’s case in detail to create a custom, groundbreaking treatment plan.
Primary Location: Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center), Baltimore, MD
Primary Location: The Johns Hopkins Hospital (Main Entrance), Baltimore, MD
Primary Location: Skip Viragh Outpatient Cancer Center, Baltimore, MD
Research Interests: Urothelial cancers, Small cell bladder cancer, Women’s bladder cancer
Primary Location: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Primary Location: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
